U.S. Food Stock News

Lockheed Martin stock has delivered a 55.1% total return over the past 5 years, yet current checks suggest the shares may still trade below an intrinsic value estimate, with both the Discounted Cash Flow (DCF) work and earnings multiples pointing to upside compared with the recent price near US$514.99. At the same time, the share price has eased in the short term, which raises the question of whether the pullback is creating a valuation opportunity or simply reflecting execution and contract...

Analyst debate after 'Moana' remake and streaming questions Walt Disney (DIS) is back in focus after its live action "Moana" remake underperformed earlier expectations at the box office, coinciding with analyst calls to reconsider the company’s commitment to direct to consumer streaming. This combination of a high profile release and fresh commentary from firms such as Wells Fargo has pushed investors to reassess how Disney’s extensive intellectual property and streaming platforms fit into...

Recent commentary has revisited Blackstone’s mixed valuation, highlighting the balance between its large-scale, diversified platform and lingering headwinds tied to real estate exposure and uncertain asset realizations. An interesting takeaway is how fair-value models hint at potential upside even as traditional market multiples paint a more demanding picture for the firm. We’ll now examine how this renewed focus on valuation risks and real estate exposure could reshape Blackstone’s existing...

Stubborn inflation risk, the possibility of US CPI moving toward 5–6%, and 10 year Treasury yields that could head toward 8% are reshaping how investors think about both risk and opportunity across markets. Higher bond yields can pressure stock valuations, while a more hawkish Federal Reserve, now led by Kevin Warsh, may pull some of that pressure in the other direction. In this environment, commodity related producers stand out as one way to adjust exposure. This article breaks down three...

Regulatory shift puts GH Research (NasdaqGM:GHRS) in focus The US Food and Drug Administration’s finalized guidance on psychedelic drug development, along with a planned public hearing on supervised psychedelic use, has put GH Research (NasdaqGM:GHRS) firmly back on investors’ radar. This clearer regulatory direction may influence how investors think about regulatory risk, sector accessibility, and valuation frameworks for clinical-stage psychedelic developers, particularly those targeting...

After a very strong five year run that has seen General Electric return about 473%, the valuation backdrop has become more contentious, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the stock trades at a premium even as standard earnings multiples look roughly in line with peers. The roughly 473% total return over five years puts General Electric among the stronger performers in its sector, which naturally raises the bar for what counts as an appealing entry price...

Multiple class action lawsuits allege Intuit and certain executives made false or misleading statements about TurboTax’s competitive position and growth. Regulators have opened legal investigations following workforce layoffs and weaker than expected tax season results. The company has acknowledged underperformance in parts of the tax business, contrasting with earlier public commentary highlighted in the lawsuits. Shareholders are assessing potential impacts on NasdaqGS:INTU related to...

Trade Desk (NasdaqGM:TTD) has launched a major retail data integration with SEVEN-ELEVEN JAPAN. The partnership allows advertisers in Japan to use retail purchase data from 28 million 7-Eleven App members across digital channels. The integration focuses on scalable, always-on audience targeting that aims to respect consumer privacy requirements. Trade Desk operates a global advertising technology platform that connects advertisers to digital media across formats such as display, video, and...

ASML Holding (NasdaqGS:ASML) reports strong Q2 2026 results and raises its quarterly and full-year 2026 sales and margin guidance. Intel Foundry uses ASML's High NA EUV tools for production chips, marking the first high-volume output on this new lithography standard. Management cites robust AI-related demand and outlines plans for significant capacity expansion to support customers. ASML Holding sits at the center of advanced chip production, supplying lithography systems that are essential...

GRAIL (GRAL) is in focus after multiple law firms filed securities fraud class action lawsuits, following disclosure that its NHS Galleri cancer trial did not meet its primary endpoint and was linked to sharp investor losses. See our latest analysis for GRAIL. After the initial 50% drop following the NHS Galleri trial disclosure, GRAIL's recent momentum has picked up, with a 30 day share price return of 22.17% and a 90 day share price return of 46.86%. The 1 year total shareholder return...

Upcoming Q2 earnings put Republic Services in focus Republic Services (RSG) is back in the spotlight as it heads toward its fiscal second quarter 2026 earnings release on Thursday, August 6, after the market close. This update is one that many investors watch closely. Analysts expect profit of $1.81 per share for the quarter, compared with the same period a year ago. Republic Services has met or exceeded Wall Street EPS estimates in each of the last four quarters. See our latest analysis for...

Salesforce (NYSE:CRM) is seeing fresh product momentum as Quik! and High Meadow Solutions launch Quik! for Salesforce to bring AI-driven, form-based advisor workflows directly into the CRM. DataGroomr has rolled out real-time cross-object duplicate prevention on Salesforce, targeting cleaner data across Leads, Contacts, and other core records. These updates arrive as Salesforce trades around $167.56 and continues to position itself as a core platform for AI, compliance workflows, and data...

Clinical trial setback shifts attention to Regeneron Pharmaceuticals pipeline Regeneron Pharmaceuticals (REGN) is back in focus after disappointing clinical trial results for one of its pipeline drugs, which weighed on recent performance and pushed investor attention toward unmet development milestones. At the same time, therapies Dupixent and Eylea remain key anchors for the business. Regeneron Pharmaceuticals has been repurchasing shares and avoiding value destructive acquisitions, a...

The Vita Coco Company recently reported that Q1 2026 revenue rose 37% year over year to US$180 million, with gross margins improving to 40% and management lifting full-year sales and EBITDA guidance. An interesting angle is that the company achieved this stronger outlook while maintaining a debt-free balance sheet and holding about US$200 million in cash, even though it still depends heavily on its core coconut water brand and a relatively concentrated customer base. We’ll now explore how...

Vertex Pharmaceuticals (NasdaqGS:VRTX) agreed to acquire Crinetics Pharmaceuticals in a US$10b all cash transaction. The deal brings atumelnant, an advanced clinical stage drug candidate for congenital adrenal hyperplasia, into Vertex's pipeline. The acquisition marks a move by Vertex into adrenal disease therapeutics, expanding beyond its traditional focus areas. For investors following Vertex Pharmaceuticals, this deal signals a push beyond the company’s established franchises and into...

We wouldn't blame SharkNinja, Inc. ( NYSE:SN ) shareholders if they were a little worried about the fact that CJ Xuning...

The global electric vehicle (EV) market is expected to reach $2.74 trillion by 2026, bolstered by investments in charging infrastructure and battery technology. The market's development is shaped by differing regional policies, with Europe, China, and the United States taking varied approaches to regulations and infrastructure. These investments and regulatory changes are fostering regionalized markets, necessitating localized strategies for automakers. The evolving competitive landscape is...

We wouldn't blame Arcus Biosciences, Inc. ( NYSE:RCUS ) shareholders if they were a little worried about the fact that...

The proposed US$53b bid by Stripe and Advent International for PayPal has pushed digital payments and broader fintech back into the spotlight, with a 28% offer premium hinting at how highly some buyers value this space. For investors, that kind of interest can reshape expectations across the sector, from transaction platforms to tech driven financial services. This article looks at three fintech stocks from our Fintech Sector Stocks screener that are closely tied to this news and explains how...

Arcos Dorados Holdings has delivered a 66.4% gain over the past five years, yet current valuation work suggests the stock may still trade below its intrinsic value, even after a softer recent patch for the share price. Arcos Dorados Holdings is up 66.4% over five years, which puts the current debate squarely on whether that longer term return already reflects the value in the business. The planned redemption of the 6.125% sustainability linked senior notes can support lower interest costs...

Equity Bancshares, Inc. reported second-quarter 2026 results showing net interest income of US$73.87 million, net income of US$26.44 million, basic EPS of US$1.28, and net charge-offs of US$1.7 million, while completing a buyback of 883,707 shares for US$39.09 million. Together, the earnings strength, controlled credit costs, and completion of a multi-quarter share repurchase program highlight management’s focus on profitability and capital deployment. Next, we’ll examine how this strong...

Coinbase Global reportedly began accepting Chinese national IDs for customer verification, potentially opening its platform to more users from mainland China. The move comes while China continues to maintain a ban on crypto trading, raising legal and regulatory questions. This development introduces fresh uncertainty around Coinbase's international compliance approach and its exposure to cross border regulatory tensions. Coinbase Global, traded as NasdaqGS:COIN, has a current share price of...

MetLife (MET) has affirmed its shareholder payout plans, with the board declaring a third quarter 2026 common stock dividend of $0.5925 per share, payable on September 8 to holders of record on August 4. See our latest analysis for MetLife. At a share price of $92.54, MetLife has seen a 30 day share price return of 4.16% and a 90 day share price return of 19.38%. The 1 year total shareholder return of 25.07% and 5 year total shareholder return of 86.76% indicate a strong longer term outcome,...

Construction Partners (ROAD) has been in focus after completing its acquisition of Ellsworth Construction in Oklahoma, widening its footprint in the Tulsa and Oklahoma City markets and adding asphalt manufacturing and construction capacity. See our latest analysis for Construction Partners. Despite the Ellsworth acquisition and an upcoming fiscal Q3 results date on 7 August 2026, Construction Partners’ recent share price performance has softened, with the 30 day share price return down 14.5%...